Chronic inflammation as predictor of 1-year hospitalization and mortality in elderly population

European Journal of Clinical Investigation

Volumn 42, Issue 10, 2012, Pages 1037-1046

  de Gonzalo Calvo, David ^a   de Luxán Delgado, Beatriz ^a   Martínez Camblor, Pablo ^b   Rodríguez González, Susana ^a   García Macia, Marina ^a   Suárez, Francisco M ^c   Solano, Juan J ^d   Rodríguez Colunga, María J ^a   Coto Montes, Ana ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b Bio sanitary Investigation Office (OIB)   (Spain)

^c Regional Health Ministry of Principado de Asturias   (Spain)

^d Monte Naranco Hospital   (Spain)

Author keywords

Chronic inflammation; Hospitalization; Interleukin 1 receptor antagonist; Mortality; Red cell distribution width; Tumour necrosis factor

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CELLULAR DISTRIBUTION; CHRONIC INFLAMMATION; ERYTHROCYTE; FEMALE; FUNCTIONAL STATUS; HOSPITALIZATION; HUMAN; INSTITUTIONALIZATION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NURSING HOME; PREDICTOR VARIABLE; PRIORITY JOURNAL; SPAIN; SURVIVOR;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHRONIC DISEASE; ERYTHROCYTES; FEMALE; HOSPITALIZATION; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; PROGNOSIS; RISK FACTORS; SPAIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866266288     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2012.02689.x     Document Type: Article

References (39)

1. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev 2009;8:18-30.
2. Brüünsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am 2003;23:15-39.
3. Schett G. Effects of inflammatory and anti-inflammatory cytokines on the bone. Eur J Clin Invest 2011;12:1361-6.
4. Cesari M, Penninx BW, Pahor M, Lauretani F, Corsi AM, Rhys Williams G et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004;59:242-48.
5. Penninx BW, Kritchevsky SB, Newman AB, Nicklas BJ, Simonsick EM, Rubin S et al. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc 2004;52:1105-13.
6. Riva E, Tettamanti M, Mosconi P, Apolone G, Gandini F, Nobili A et al. Association of mild anemia with hospitalization and mortality in the elderly: the Health and Anemia population-based study. Haematologica 2009;94:22-8.
7. Volpato S, Onder G, Cavalieri M, Guerra G, Sioulis F, Maraldi C et al. Characteristics of nondisabled older patients developing new disability associated with medical illnesses and hospitalization. J Gen Intern Med 2007;22:668-74.
8. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. the index of Adl: a standardized measure of biological and psychosocial function. JAMA 1963;185:914-19.
9. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965;14:61-5.
10. Cohen HJ, Harris T, Pieper CF. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 2003;114:180-7.
11. Tiainen K, Hurme M, Hervonen A, Luukkaala T, Jylha M. Inflammatory markers and physical performance among nonagenarians. J Gerontol A Biol Sci Med Sci 2010;65:658-63.
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
13. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464-78.
14. de Gonzalo-Calvo D, de Luxan-Delgado B, Rodriguez-Gonzalez S, Garcia-Macia M, Suarez FM, Solano JJ et al. Oxidative protein damage is associated with severe functional dependence among the elderly population: a principal component analysis approach. J Gerontol A Biol Sci Med Sci 2011;doi: 10.1093/gerona/glr1215.
15. de Gonzalo-Calvo D, Neitzert K, Fernandez M, Vega-Naredo I, Caballero B, Garcia-Macia M et al. Differential inflammatory responses in aging and disease: TNF-alpha and IL-6 as possible biomarkers. Free Radic Biol Med 2010;49:733-7.
16. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
17. WHO. Global Recommendations on Physical Activity for Health. Geneva: World Health Organization; 2010.
18. Van Zee KJ, Kohno T, Fischer E, Rock CS, Moldawer LL, Lowry SF. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A 1992;89:4845-9.
19. Stowe RP, Peek MK, Cutchin MP, Goodwin JS. Plasma cytokine levels in a population-based study: relation to age and ethnicity. J Gerontol A Biol Sci Med Sci 2010;65:429-33.
20. Jylha M, Paavilainen P, Lehtimaki T, Goebeler S, Karhunen PJ, Hervonen A et al. Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study. J Gerontol A Biol Sci Med Sci 2007;62:1016-21.
21. Albani D, Tettamanti M, Batelli S, Polito L, Dusi S, Ateri E et al. Interleukin-1alpha, interleukin-1beta and tumor necrosis factor-alpha genetic variants and risk of dementia in the very old: evidence from the "Monzino 80-plus" prospective study. Age (Dordr) 2012;2:519-26.
22. Cavallone L, Bonafe M, Olivieri F, Cardelli M, Marchegiani F, Giovagnetti S et al. The role of IL-1 gene cluster in longevity: a study in Italian population. Mech Ageing Dev 2003;124:533-8.
23. de Gonzalo-Calvo D, Fernández-García B, de Luxán-Delgado B, Rodríguez-González S, García-Macia M, Suárez FM et al. Long-term training induces a healthy inflammatory and endocrine emergent biomarker profile in elderly men. Age (Dordr) 2012;3:761-71.
24. Hotamisligil GS. The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999;245:621-5.
25. Ferrucci L, Corsi A, Lauretani F, Bandinelli S, Bartali B, Taub DD et al. The origins of age-related proinflammatory state. Blood 2005;105:2294-9.
26. Jacobs M, van Greevenbroek MMJ, van der Kallen CJH, Ferreira I, Blaak EE, Feskens EJM et al. Low-grade inflammation can partly explain the association between the metabolic syndorme and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. Eur J Clin Invest 2009;39:437-44.
27. Topinkova E. Aging, disability and frailty. Ann Nutr Metab 2008;52(Suppl. 1):6-11.
28. Mooradian AD, Reed RL, Osterweil D, Scuderi P. Detectable serum levels of tumor necrosis factor alpha may predict early mortality in elderly institutionalized patients. J Am Geriatr Soc 1991;39:891-4.
29. Engstrom G, Segelstorm N, Ekberg-Aronsson M, Nilsson PM, Lindgarde F, Lofdahl CG. Plasma markers of inflammation and incidence of hospitalisations for COPD: results from a population-based cohort study. Thorax 2009;64:211-5.
30. Bilim O, Takeishi Y, Kitahara T, Ishino M, Sasaki T, Suzuki S et al. Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure. J Card Fail 2010;16:873-9.
31. Hamerman D. Toward an understanding of frailty. Ann Intern Med 1999;130:945-50.
32. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci 1997;52:M201-8.
33. Ferrucci L, Guralnik JM, Woodman RC, Bandinelli S, Lauretani F, Corsi AM et al. Proinflammatory state and circulating erythropoietin in persons with and without anemia. Am J Med 2005;118:1288.
34. Semba RD, Patel KV, Ferrucci L, Sun K, Roy CN, Guralnik JM et al. Serum antioxidants and inflammation predict red cell distribution width in older women: the Women's Health and Aging Study I. Clin Nutr 2010;29:600-4.
35. Dayhoff-Brannigan M, Ferrucci L, Sun K, Fried LP, Walston J, Varadhan R et al. Oxidative protein damage is associated with elevated serum interleukin-6 levels among older moderately to severely disabled women living in the community. J Gerontol A Biol Sci Med Sci 2008;63:179-83.
36. Patel KV, Ferrucci L, Ershler WB, Longo DL, Guralnik JM. Red blood cell distribution width and the risk of death in middle-aged and older adults. Arch Intern Med 2009;169:515-23.
37. Patel KV, Semba RD, Ferrucci L, Newman AB, Fried LP, Wallace RB et al. Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci 2010;65:258-65.
38. Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation 2008;117:163-8.
39. Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997;43:52-8.